Dr. Neels Van der Schyf – the owner and author of BlushBrain, holds baccalaureate and master’s degrees in Pharmacy, Pharmaceutical and Medicinal Chemistry, and a doctorate in Medicinal Chemistry. He completed a postdoctoral fellowship in the Department of Medicinal Chemistry, University of Connecticut and the National Magnet Lab at MIT, Cambridge, MA. He is currently Vice President for Research and Dean of the Graduate School at Idaho State University (ISU), and a tenured full professor of Biomedical and Pharmaceutical Sciences in ISU’s College of Pharmacy. Prior to joining ISU, Van der Schyf was Associate Dean for Research & Graduate Studies, Founding Chair and Professor of Pharmaceutical Sciences in the College of Pharmacy, and Professor of Neurobiology in the College of Medicine at Northeast Ohio Medical University (NEOMED). Dr. Van der Schyf is a world recognized researcher and expert in neurodegenerative diseases, predominantly focusing on Alzheimer’s and Parkinson’s disease, and ocular neurodegeneration. His research career in these areas spans more than 30 years.
Currently, he has published more than 120 peer-reviewed research and review articles, 205 abstracts and presentations – many of these as invited keynote speaker; 10 book chapters, several reports to industry, and numerous journal editorials. He holds 14 patents. Most of his work focuses on the pathology of neurodegenerative diseases and the design of medications to treat these diseases, and his research has been cited more than 3,000 times in the scientific literature. He is or has been either editor-in-chief, or member of the editorial advisory boards for 12 international research journals in neurodegenerative diseases and drug discovery, and an invited guest editor for two. Van der Schyf served as visiting professor in Australia, Belgium, the USA, and South Africa.
In addition to serving on several US NIH Study Sections, the Alzheimer’s Association and many other national and international research granting agencies (including in the UK, Portugal, South Africa and the Russian Federation), he is a member of Phi Beta Delta and Sigma Xi, and has received several “Teacher of the Year” and “Most Cited Paper” awards, the APSSA Upjohn Achievement Award and South Africa’s highest honor in drug discovery research, the FARMOVS Prize for Pharmacology and Drug Development. Van der Schyf is also the recipient of the 2010 Olson/Blair Award. He has been the major advisor for more than 20 graduate students since 1985 (11 PhDs, remainder MS degrees) and served on the graduate committees of more than 30 additional graduate students, all doing research in neurodegenerative diseases and drug discovery.
He has been listed in Who’s Who in Medicine and Healthcare, and in Who’s Who South Africa.